Novome and Genentech enter into a strategic collaboration to develop targets against IBD

时间：2021-11-10

Nov 10, 2021 — Collaboration will leverage Novome’s GEMMs platform for colonizing the human gut with therapeutically engineered bacteria

和度生物医药（上海）有限公司 沪ICP备2021004953号-1